Nuclear factor erythroid 2-related factor 2 (Nrf2) [28] was one of the novel targets in the treatment of stroke due to its ability to induce the antioxidative potential of the cell especially in neurons by cooperating with its actin-binding protein Keap1 [43,44]. This evidence concerns the gene KEAP1 and Stroke.